Patents Assigned to PANTHERYX, INC.
  • Patent number: 12263192
    Abstract: Effective and economical compositions and methods are disclosed for the treatment, and prevention of diseases and disorders associated with inflammation and/or damage to the gastrointestinal tract, including environmental enteric dysfunction. Compositions are provided comprising a synergistic combination of colostrum, immune egg, and optionally one or more additional active agents.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: April 1, 2025
    Assignee: PanTheryx, Inc.
    Inventors: Mark Grabowsky, Raymond J. Playford, Timothy W. Starzl, Tania Marchbank, Paul Kelly, Naheed Choudhry
  • Publication number: 20220362303
    Abstract: Compositions are provided comprising a pro-reparative factor such as a colostrum, a nutritional protease inhibitor to decrease enzymatic digestion of the pro-reparative factors, and optionally a stabilizing agent, to allow the pro-reparative factors to reach the small intestine intact following oral administration. Methods are provided for treating, alleviating, and preventing inflammatory bowel disease (IBD) and other disorders of the gastrointestinal tract.
    Type: Application
    Filed: February 25, 2022
    Publication date: November 17, 2022
    Applicant: PanTheryx, Inc.
    Inventors: Raymond John Playford, Michael James Weiser, Tania Marchbank, Sandra Johanna Maria ten Bruggencate, George Stagnitti
  • Patent number: 10611828
    Abstract: The disclosure provides improved compositions and methods for passive immunization. In embodiments, a composition comprising a synergistic combination of specific polyclonal antibodies in a carrier matrix is provided. The disclosure provides effective, economical compositions and methods for the treatment of diarrhea and enteric infections in broad-spectrum, undifferentiated, or mixed clinical applications.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: April 7, 2020
    Assignee: PANTHERYX, INC.
    Inventor: Timothy W. Starzl
  • Patent number: 9701735
    Abstract: The disclosure provides improved compositions and methods for passive immunization. In embodiments, a composition comprising a synergistic combination of specific polyclonal antibodies in a carrier matrix is provided. The disclosure provides effective, economical compositions and methods for the treatment of diarrhea and enteric infections in broad-spectrum, undifferentiated, or mixed clinical applications.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: July 11, 2017
    Assignee: PANTHERYX, INC.
    Inventor: Timothy W. Starzl
  • Publication number: 20120141458
    Abstract: The disclosure provides improved compositions and methods for passive immunization. In embodiments, a composition comprising a synergistic combination of specific polyclonal antibodies in a carrier matrix is provided. The disclosure provides effective, economical compositions and methods for the treatment of diarrhea and enteric infections in broad-spectrum, undifferentiated, or mixed clinical applications.
    Type: Application
    Filed: November 22, 2011
    Publication date: June 7, 2012
    Applicant: PANTHERYX, INC.
    Inventor: Timothy W. Starzl